PEOPLE TAKING GLP-1S have a reduced risk of heart attacks, strokes, and death from cardiovascular disease, according to a ...
Nearly 2 in 3 people without diabetes quit popular weight loss drugs such as Ozempic or Victoza within one year, according to ...
Among over 125,000 patients, 53.6% discontinued their GLP-1 receptor agonist by 1 year, and these rates were significantly ...
A new study examines how cost, side effects, and other factors influence whether people stop GLP-1s, while Noom cuts staff to ...
(liraglutide) weight loss in adults and children ages 12 years ... Avoid compounded drugs marketed as semaglutide, and only take FDA-approved semaglutide products — such as Wegovy, Ozempic ...
Ozempic can cause bone density loss and I didn't think that would happen to me because I was only on it for a year. But I ...
A new study conducted by researchers from the University of Eastern Finland the Karolinska Institutet explored the ways that ...
Maintaining a healthy weight is good for your body and can also help with self-esteem. If you’ve been trying to lose weight, ...
GLP-1 agonists for weight loss are now commonly used for adults, but might they also be an effective treatment for younger people? Katharine Lang reports Obesity in children and adolescents is a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback